- Rapid spread of India Covid variant in UK is ‘worrying’, say scientists
- Ministers among main routes for Covid PPE deal ‘VIP’ channel, court hears
- See all our coronavirus coverage
Indonesia’s drug regulator on Friday approved a Covid vaccine produced by China’s Sinopharm, which is due to be used in a private vaccination scheme under which companies can buy government-procured vaccines to inoculate their staff, Reuters reports.
No detailed efficacy data of Sinopharm’s vaccine has been publicly released, but its developer, Beijing Biological Products Institute, a unit of Sinopharm subsidiary China National Biotec Group, said the vaccine was 79.34% effective in preventing people from developing the disease, based on interim data.
India posted a record daily rise in coronavirus cases of 386,452 on Friday, while deaths from Covid-19 jumped by 3,498 over the last 24 hours, according to health ministry data.
Read the original article at The Guardian